Baker Lh
Impact in
-
- Cancer Treatment and Pharmacology
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Metal complexes synthesis and properties
Papers in
-
- Lung Cancer Treatments and Mutations 7
- Oncology 12
- Cancer Treatment and Pharmacology 4
- Lung Cancer Research Studies 3
- Co-authors
- Jones Se (2 shared papers)Joseph M. Quagliana (1 shared paper)Richard Stephens (1 shared paper)J J Costanzi (1 shared paper)E. Gehan (1 shared paper)Weick Jk (1 shared paper)Talley Rw (3 shared papers)Glenn Cummings (4 shared papers)
- Journals
- Journal of Clinical Oncology (1 paper)European Journal of Cancer (1 paper)Lung Cancer (1 paper)PubMed (29 papers)
- Partner nations
- United States
In The Last Decade
Baker Lh
31 papers receiving 286 citations
Peers
Comparison fields: 5 of 64
- Oncology 195
- Toxicology 11
- Hepatology 23
- Pulmonary and Respiratory Medicine 81
- Pathology and Forensic Medicine 40
Countries citing papers authored by Baker Lh
This map shows the geographic impact of Baker Lh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baker Lh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baker Lh more than expected).
Fields of papers citing papers by Baker Lh
This network shows the impact of papers produced by Baker Lh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baker Lh. The network helps show where Baker Lh may publish in the future.
Co-authors
The 25 scholars most cited alongside Baker Lh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 41 | |
| 2 | Gallium nitrate in malignant lymphoma: a Southwest Oncology Group study. | 1983 | 27 |
| 3 | Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study. | 1977 | 25 |
| 4 | Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer. | 1976 | 24 |
| 5 | Phase I clinical trial of combined therapy with vinblastine (NSC-49842), bleomycin (NSC-125066), and cisdichlorodiammineplatinum(II)( NSC-119875). | 1976 | 18 |
| 6 | Phase II study of AMSA in lung cancer. | 1981 | 17 |
| 7 | Phase I study of oral mitomycin C. | 1976 | 16 |
| 8 | Phase I-II clinical trial of gallium nitrate (NSC-15200). | 1980 | 15 |
| 9 | Preliminary experiences with intra-arterial adriamycin. | 1977 | 14 |
| 10 | Phase I--II study of intermittent bolus administration of DTIC and actinomycin D in metastatic malignant melanoma. | 1978 | 14 |
| 11 | Mitomycin C and bleomycin in the treatment of far-advanced cervical cancer: a Southwest Oncology Group pilot study. | 1981 | 14 |
| 12 | Phase II trial of tamoxifen in malignant melanoma. | 1982 | 12 |
| 13 | American experience with carminomycin. | 1979 | 10 |
| 14 | Phase I study of echinomycin. | 1987 | 10 |
| 15 | Gallium nitrate in advanced soft tissue and bone sarcomas: a Southwest Oncology Group Study. | 1982 | 10 |
| 16 | Bony metastasis from adenocarcinoma of the colon. | 1974 | 9 |
| 17 | Use of VM-26 as a single agent in the treatment of renal carcinoma. | 1979 | 9 |
| 18 | Phase II evaluation of gallium nitrate in breast cancer: a Southwest Oncology Group Study. | 1982 | 8 |
| 19 | Evaluation of gallium nitrate in metastatic or locally recurrent squamous cell carcinoma of the head and neck: a Southwest Oncology Group study. | 1984 | 8 |
| 20 | Clinical trial of chlorozotocin, DTIC, and dactinomycin in metastatic malignant melanoma. | 1982 | 7 |
About Baker Lh
Baker Lh is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 32 papers that have together received 352 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Cancer therapeutics and mechanisms (6 papers), Cancer Treatment and Pharmacology (4 papers), Ovarian cancer diagnosis and treatment (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Antifungal resistance and susceptibility (3 papers), Lung Cancer Research Studies (3 papers) and Infectious Diseases and Mycology (3 papers). The work is most often cited by research in Oncology (195 citations), Toxicology (11 citations), Hepatology (23 citations), Pulmonary and Respiratory Medicine (81 citations) and Pathology and Forensic Medicine (40 citations). Baker Lh has collaborated with scholars based in United States. Frequent co-authors include Jones Se, Joseph M. Quagliana, Richard Stephens, J J Costanzi, E. Gehan, Weick Jk, Talley Rw, Glenn Cummings, Michael K. Samson and Priyanka A. Shah. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Lung Cancer and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.